202 Spam-Free Article(s) Found
Article Searches
Broadfin Capital, LLC Buys Adamas Pharmaceuticals Inc, La Jolla Pharmaceutical Co, AMAG ... http://www.gurufocus.com/news/682301/broadfin-capital-llc-buys-adamas-pharmaceuticals-inc-la-jolla-pharmaceutical-co-amag-pharmaceuticals-inc-sells-ignyta-inc-endo-international-plc-mirati-therapeutics-inc May 14, 2018 - Broadfin Capital, LLC Buys Adamas Pharmaceuticals Inc, La Jolla Pharmaceutical Co, AMAG Pharmaceuticals Inc, Sells Ignyta Inc, Endo International PLC, Mirati Therapeutics Inc, Stocks: LJPC,NUVA,GWPH,VCEL,AMRN,ADMS,AMAG,KALA,GKOS,ANAB,, release date:May 14, 2018
Tekla Capital Management LLC Buys Pfizer Inc, Johnson & Johnson, Esperion Therapeutics Inc, ... http://www.gurufocus.com/news/681743/tekla-capital-management-llc-buys-pfizer-inc-johnson--johnson-esperion-therapeutics-inc-sells-alexion-pharmaceuticals-inc-biomarin-pharmaceutical-inc-shire-plc May 14, 2018 - Tekla Capital Management LLC Buys Pfizer Inc, Johnson & Johnson, Esperion Therapeutics Inc, Sells Alexion Pharmaceuticals Inc, Biomarin Pharmaceutical Inc, Shire PLC, Stocks: PFE,JNJ,BMY,ANTM,ABBV,GWPH,ESPR,NKTR,MDCO,BPMC,CRS, release date:May 14, 2018
GW Pharmaceuticals' (GWPH) CEO Justin Gover on Q2 2018 Results - Earnings Call Transcript https://seekingalpha.com/article/4171471-gw-pharmaceuticals-gwph-ceo-justin-gover-q2-2018-results-earnings-call-transcript?source=feed_sector_healthcare May 08, 2018 - GW Pharmaceuticals plc (NASDAQ:GWPH) Q2 2018 Earnings Conference Call May 08, 2018 04:30 PM ET Executives Stephen Schultz - Vice President, Investor Relations Justin Gover - Chief Executive Officer Sc
GW Pharmaceuticals (GWPH) Stock Moving Higher After Posting Q2 Earnings http://www.zacks.com/stock/news/302809/gw-pharmaceuticals-gwph-stock-moving-higher-after-posting-q2-earnings?cid=CS-ZC-FT-302809 May 08, 2018 - GW Pharmaceuticals PLC (GWPH) just released its latest quarterly financial results, posting adjusted earnings of -$3.12 per share and revenues of $3.35 million.
What's in Store for Radius Health (RDUS) in Q1 Earnings? http://www.zacks.com/stock/news/302550/whats-in-store-for-radius-health-rdus-in-q1-earnings?cid=CS-ZC-FT-302550 May 07, 2018 - Investors are expected to focus on the uptake of lead drug, Tymlos, and other pipeline developments when Radius Health (RDUS) reports results for the first quarter.
Mylan (MYL) to Report Q1 Earnings: What's in the Offing? http://www.zacks.com/stock/news/302607/mylan-myl-to-report-q1-earnings-whats-in-the-offing?cid=CS-ZC-FT-302607 May 07, 2018 - Investors are exepcted to focus on the performance of EpiPen, newly launched drugs and the progress of the company's biosimilars pipeline when Mylan (MYL) reports results for the Q1.
Will Tinder Gold Drive Match Group's (MTCH) Q1 Earnings? http://www.zacks.com/stock/news/302408/will-tinder-gold-drive-match-groups-mtch-q1-earnings?cid=CS-ZC-FT-302408 May 04, 2018 - Match Group's (MTCH) first-quarter 2018 earnings to benefit from steady market traction of apps like Tinder, which are driving higher subscriber growth.
What's in Store for Prothena (PRTA) This Earnings Season? http://www.zacks.com/stock/news/302348/whats-in-store-for-prothena-prta-this-earnings-season?cid=CS-ZC-FT-302348 May 04, 2018 - Prothena (PRTA) has faced quite a few setbacks in the year so far and hence investors will be focused on management's strategy when it reports first-quarter results next week.
GW Pharma (GWPH) Q2 Earnings: Is a Turnaround in the Cards? http://www.zacks.com/stock/news/301700/gw-pharma-gwph-q2-earnings-is-a-turnaround-in-the-cards?cid=CS-ZC-FT-301700 May 01, 2018 - GW Pharma (GWPH) is expected to report its fiscal second-quarter results next week. Investors focus is expected to be on commercialization plan for Epidiolex.
Alcohol Stocks Fighting To Stay Relevant In A Marijuana Stock Market? https://seekingalpha.com/article/4166835-alcohol-stocks-fighting-stay-relevant-marijuana-stock-market?source=feed_tag_etf_portfolio_strategy Apr 27, 2018 - For 30 days the marijuana industry has seen some of the biggest government support to date.Many vice stocks are reporting lagging sales in one segment or another and it could be due to changing consum

Pages: 123456...21

Page 1>
DeepLinks for GW Pharmaceuticals Plc
GWPH - Google Finance https://www.google.com/finance?q=GWPH Industry related info and international coverage Summary News
GWPH - Bloomberg http://www.bloomberg.com/research/stocks/snapshot/snapshot.asp?ticker=GWPH Original news and commentary from Bloomberg Charts Financials with pensions Snapshot Earnings Transactions People Options